ErlySign in the News – Media Coverage & Press Releases

ErlySign secures ₹16 Cr in funding for next-gen diagnostics 'Big Whale' invests in Curo Biosciences Lumos Health Accelerator onboards startups in early cancer detection 'Big Whale' invests in Curo Biosciences Lumos Health Accelerator onboards startups in early cancer detection 'Big Whale' invests in Curo Biosciences Lumos Health Accelerator onboards startups in early cancer detection

Stay Informed, Stay Ahead

Explore insights, stories, and research on oral health and the power of early detection.

Diagnosis of oral cancer in 15 minutes through saliva test ... thanks to a professor's ingenuity ...

The highest number of oral cancer patients in the country are found in Central India,including Nagpur. The number of these patients is not less in other areas as well.

Nagpur startup ErlySign develops 15-minute saliva test for oral cancer

‘Big Whale’ invests in Curo Biosciences to develop oral cancer detection kit

Cutting-Edge Cancer Detection: ErlySign's Saliva Test Explained

Our Mission, Visualized

All posts

Diagnosis of oral cancer in 15 minutes through saliva test ...

The highest number of oral cancer patients in the country are found in Central India,including Nagpur. The number of these patients is not less in other areas as well.

Nagpur startup ErlySign develops 15-minute saliva test for oral cancer

Nagpur-based biotech startup ErlySign has claimed to have developed India’s first saliva-based test for detecting oral precancerous conditions, delivering results in 15 minutes. This technology…

'Big Whale' invests in Curo Biosciences to develop oral cancer detection kit

CURO Biosciences, a Nagpur-based company, has secured an investment of Rs16 crore from Ashish Kacholia, co-founder of Hungama Digital Media Entertainment, also known

Cutting-Edge Cancer Detection: ErlySign Saliva Test Explained

Cancer remains one of the leading causes of death worldwide, with late detection often being the primary culprit. The journey to early diagnosis is typically marked by invasive, …

ErlySign raises Rs 16 Cr in Pre-Series A funding round to launch oral ...

Mumbai-based startup CURO Biosciences Private Limited, also known as ErlySign, has secured Rs 16 crore in pre-Series A funding from renowned investor Ashish Kacholia.

Ashish Kacholia invests in this healthtech startup

ErlySign is India’s first-ever salivary biomarker-based test which can identify pre-cancerous conditions much before visible symptoms emerge, revolutionising proactive healthcare and early diagnosis.

ErlySign raises Rs 16 crore from Ashish Kacholia to advance oral ...

ErlySign, formally known as CURO Biosciences, has raised Rs 16 crore in a pre-Series A funding round led by veteran investor Ashish Kacholia.

CURO Biosciences Secures ₹16 cr for advancing saliva-based cancer...

ErlySign’s innovation is a biomarker-based test kit capable of detecting oral precancerous conditions within just 15 minutes using a simple, non-invasive saliva sample

ErlySign raises $1.8 Mn in pre-Series A round from Ashish Kacholia

Healthtech startup ErlySign has raised Rs 16 crore ($1.8 million) in its pre-Series A round from Ashish Kacholia.

ErlySign Bags INR 16 Cr To Develop Cancer Diagnostic Solutions

The fresh proceeds will be deployed in clinical trials, securing CDSCO (Central Drugs Standard Control Organisation) approvals, and bringing ErlySign’s oral cancer detection kit to market

CDSCO approves ErlySign’s oral cancer detection technology

Following a comprehensive year-long investigation and based on in-house validation data of 150 test samples, the Indian Regulatory Authority CDSCO has granted permission

ERLYSIGN gets CDSCO approval for large-scale clinical trials

ErlySign, a pioneering biotech start-up located in Nagpur, announces a significant milestone in the fight against cancer with approval from the Indian regulatory agency

Erly Sign: Transforming Diagnostic Industry Via Early Stage Detection

Oral cancer is one of the top three cancer types in men and women in Southeast Asia. And India is known as the world’s capital of oral cancer. According to the Global Adult Tobacco …

Making a difference in the lives of cancer patients

Cancer is devastating for many. With World Cancer Day just gone by, we bring you beacons of hope that are trying to make a difference in the lives of cancer patients.

World Cancer Day: Latest advancements in the early cancer...

Cancer is a complex disease of worldwide concern. Along with an improvement in outcomes, early and sensitive detection of cancer and cancer biomarkers can facilitate an understanding of cancer progression

How Erly Sign As A Biotech Startup Is Changing The Face of Cancer...

In India, cancer is the most common cause of death in adults. While cancer can affect any part of the body, oral cancer is among the top three common types in the country.

This diagnostics startup helps screen patients for oral cancer risk with...

Nagpur-based diagnostics startup Erlysign’s first test kit, an easy and quick way to screen for oral cancer through a saliva sample, is undergoing clinical trials….

89 Top Indian Medical Device Companies and Startups of 2021

This article showcases our top picks for the best Indian based Medical Device companies. These startups and companies are taking a variety of approaches to innovating…